In December, 2020, the Israeli Government approved the BNT162b2 COVID-19 vaccine andinitiated a national immunisation campaign prioritising health-care workers...
The collective benefits of herd immunity have become similar to a mantra in mass vaccinationstrategies, repeated by governments and researchers. However, the prominence...
The use of rapid lateral flow antigen testing (LFT) for SARS-CoV-2 has been questioned1–3with uncorroborated4 reports of poor LFT sensitivity. The debate surrounding...
Compared with treatment as usual, specific psychological treatments for adult outpatientswith anorexia nervosa can be associated with modest improvements in terms...
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccinesthat protect against severe disease and preferably drive herd immunity. Regulators...
As we find ourselves in the second year of a global pandemic, the question on everyone'smind is: when will this end? Much of the narrative around...
High rates of viral suppression among women starting option B+ who remain in HIV careare sustainable, and might increase, at least up to 53 months. This...
According to serological test results, the proportion of young children in our samplewith SARS-CoV-2 infection was low. Intrafamily transmission seemed more plausible...
There is now a rapid global roll-out of severe acute respiratory syndrome coronavirus2 (SARS-CoV-2) vaccines as part of the response to the COVID-19 pandemic.1...
The number of confirmed SARS-CoV-2 cases worldwide has now reached around 100 million,with 2·1 million reported deaths1 and more than 450 000 SARS-CoV-2 genomes...